Gilead gets another HIV treatment approval, extending lenacapavir's dominance

Gilead Sciences' HIV treatment arsenal is getting bigger. The leading drugmaker in the four-decade epidemic gained another FDA stamp of approval on Thursday. This time, Gilead will market ...